Regulated information

Monthly information regarding the total number of voting rights and shares making of the share capital - November2011

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Monthly information regarding the total number of voting rights and shares making of the share capital - October 2011

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Q3 2011 Sales

Vétoquinol achieved Q3 2011 sales of €68.4 million, in line with the previous year.

Jacques du Puy appointed Vétoquinol Managing Director

Lure (France), October 12, 2011 – The Vétoquinol Group announces the appointment
of Jacques du Puy as Managing Director.

Monthly information regarding the total number of voting rights and shares making of the share capital - September 2011

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Forcyl®: european launch of new drug

Lure (France), September 29, 2011 – Vétoquinol announces the European launch of Forcyl®, a new drug based on 16% concentrated marbofloxacin allowing the treatment of cattle respiratory infections with a single injection.

Monthly information regarding the total number of voting rights and shares making of the share capital - August 2011

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Monthly information regarding the total number of voting rights and shares making of the share capital - July 2011

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Vétoquinol continues to develop its product ranges and enters the brazilian market

Lure (France), August 30, 2011 – The Vetoquinol Board Meeting of August 29, 2011 reviewed the Group’s business and approved the financial statements for the first half 2011.

International expansion and new product launches

Lure (France), July 19, 2011 – Vétoquinol Group sales rose to €139.7 million in the first six months of 2011.